Abstract：
:In the July issue of Nature Medicine, Massagué and colleagues define a biphasic role for the extracellular matrix protein tenascin C as a metastatic niche component in lung colonization by breast cancer cells. These results provide a rationale for designing therapies targeting metastatic progression by disrupting its very foundations.
journal_name
Cancer Celljournal_title
Cancer cellauthors
Matei I,Ghajar CM,Lyden Ddoi
10.1016/j.ccr.2011.08.004subject
Has Abstractpub_date
2011-08-16 00:00:00pages
139-41issue
2eissn
1535-6108issn
1878-3686pii
S1535-6108(11)00272-8journal_volume
20pub_type
杂志文章相关文献
CANCER CELL文献大全abstract：:Medulloblastoma (MB) is the most common malignant brain tumor in children. Patients whose tumors exhibit overexpression or amplification of the MYC oncogene (c-MYC) usually have an extremely poor prognosis, but there are no animal models of this subtype of the disease. Here, we show that cerebellar stem cells expressi...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2011.12.021
更新日期：2012-02-14 00:00:00
abstract：:Tumorigenesis is often associated with an unbalanced protein homeostasis (proteostasis) network, which sensitizes cancer cells to drugs targeting protein quality control (PQC) regulators. In this issue of Cancer Cell, Anderson and colleagues investigated the anti-cancer activity of a new class of inhibitor against a m...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2015.10.006
更新日期：2015-11-09 00:00:00
abstract：:Chromosome rearrangements in B lymphocytes can be initiated by AID-associated double strand breaks (DSBs), with others arising by unclear mechanisms. A recent study by Barlow and colleagues in Cell reports on genomic regions, termed early replicating fragile sites, that may explain many AID-independent DSBs and create...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2013.01.017
更新日期：2013-02-11 00:00:00
abstract：:Mutations in VHL, RET, NF1, SDHB, SDHC, and SDHD can give rise to pheochromocytoma/paraganglioma. These different genetic lesions may all act by decreasing the activity of a 2-oxoglutarate-dependent oxygenase, SM-20/EglN3/PHD3, resulting in reduced apoptosis of neural crest cells during development. ...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2005.07.012
更新日期：2005-08-01 00:00:00
abstract：:In this issue of Cancer Cell, Fedoriw and colleagues characterize a potent reversible inhibitor of type I PRMTs, GSK3368715, with anti-proliferative effects on numerous cancer types. Using a combination of GSK3368715 with PRMT5 inhibitors, the authors show that a threshold of overall arginine methylation reduction nee...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2019.06.004
更新日期：2019-07-08 00:00:00
abstract：:Angiogenesis is a hallmark of solid tumors, and disruption of tumor vasculature is an active anticancer therapy in some cases. Several proteins expressed on the surface of tumor endothelium have been identified during the last decade. However, due to the expression in both physiological and tumor angiogenesis, only a ...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2007.05.004
更新日期：2007-06-01 00:00:00
abstract：:To investigate the role of signaling by the small GTPase Ral, we have generated mice deficient for RalGDS, a guanine nucleotide exchange factor that activates Ral. We show that RalGDS is dispensable for mouse development but plays a substantial role in Ras-induced oncogenesis. Lack of RalGDS results in reduced tumor i...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2005.01.029
更新日期：2005-03-01 00:00:00
abstract：:In a recent study, Leucci et al. report a role for the long non-coding RNA SAMMSON in driving mitochondrial function in melanoma. Targeting SAMMSON, the gene of which is frequently co-amplified with MITF, highlights a new cell-type-specific therapeutic vulnerability in melanoma irrespective of BRAF, NRAS, or p53 statu...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2016.04.010
更新日期：2016-05-09 00:00:00
abstract：:Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disease (MPD) initiated by expression of the p210-BCR-ABL fusion protein. We demonstrate in a murine model of p210-BCR-ABL-induced MPD that gene targeting of Rac1 and Rac2 significantly delays or abrogates disease development. Attenuation of the disease...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2007.10.015
更新日期：2007-11-01 00:00:00
abstract：:Neuropilin-1 (NRP1) guides the development of the nervous and vascular systems. Binding to either semaphorins or VEGF, NRP1 acts with plexins to regulate neuronal guidance, or with VEGFR2 to mediate vascular development. We have generated two monoclonal antibodies that bind to the Sema- and VEGF-binding domains of NRP...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2006.10.018
更新日期：2007-01-01 00:00:00
abstract：:p62 is a ubiquitin-binding autophagy receptor and signaling protein that accumulates in premalignant liver diseases and most hepatocellular carcinomas (HCCs). Although p62 was proposed to participate in the formation of benign adenomas in autophagy-deficient livers, its role in HCC initiation was not explored. Here we...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2016.04.006
更新日期：2016-06-13 00:00:00
abstract：:Glioblastoma is heterogeneous in the molecular subtypes based on transcriptomic classification. In this issue of Cancer Cell, Wang et al. define a cell-lineage-based stratification model for glioblastoma, highlighting how the cell of origin generates distinct molecular landscapes and therapeutic vulnerabilities from i...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2020.08.012
更新日期：2020-09-14 00:00:00
abstract：:Van den Eynde et al. publish in this issue of Cancer Cell that metastatic colorectal cancer shows marked heterogeneity in T cell infiltration among different lesions and patients. Measurements of T cell infiltration in metastases by immunoscore offer some prognostic information and support immune editing by coevolving...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2018.11.012
更新日期：2018-12-10 00:00:00
abstract：:Recent structural studies of epidermal growth factor receptor (EGFR) family extracellular regions have identified an unexpected mechanism for ligand-induced receptor dimerization that has important implications for activation and inhibition of these receptors. Here we describe the 2.8 angstroms resolution X-ray crysta...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2005.03.003
更新日期：2005-04-01 00:00:00
abstract：:The EZH2 histone methyltransferase is highly expressed in germinal center (GC) B cells and targeted by somatic mutations in B cell lymphomas. Here, we find that EZH2 deletion or pharmacologic inhibition suppresses GC formation and functions. EZH2 represses proliferation checkpoint genes and helps establish bivalent ch...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2013.04.011
更新日期：2013-05-13 00:00:00
abstract：:Amplification of 1q21 occurs in approximately 30% of de novo and 70% of relapsed multiple myeloma (MM) and is correlated with disease progression and drug resistance. Here, we provide evidence that the 1q21 amplification-driven overexpression of ILF2 in MM promotes tolerance of genomic instability and drives resistanc...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2017.05.011
更新日期：2017-07-10 00:00:00
abstract：:The MAP3-kinase TGF-beta-activated kinase 1 (TAK1) critically modulates innate and adaptive immune responses and connects cytokine stimulation with activation of inflammatory signaling pathways. Here, we report that conditional ablation of TAK1 in liver parenchymal cells (hepatocytes and cholangiocytes) causes hepatoc...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2010.03.021
更新日期：2010-05-18 00:00:00
abstract：:The SH2-containing tyrosine phosphatase Shp2 (PTPN11) is required for growth factor and cytokine signaling. Germline Shp2 mutations cause Noonan Syndrome (NS), which is associated with increased risk of juvenile myelomonocytic leukemia (JMML). Somatic Shp2 mutations occur in sporadic JMML and other leukemias. We found...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2005.01.010
更新日期：2005-02-01 00:00:00
abstract：:A key characteristic of stem cells and cancer cells is their ability to self-renew. To test if Wnt signaling can regulate the self-renewal of both stem cells and cancer cells in the hematopoietic system, we developed mice that lack beta-catenin in their hematopoietic cells. Here we show that beta-catenin-deficient mic...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2007.11.003
更新日期：2007-12-01 00:00:00
abstract：:Atypical protein kinase C (aPKC) isozymes, PKCλ/ι and PKCζ, are now considered fundamental regulators of tumorigenesis. However, the specific separation of functions that determine their different roles in cancer is still being unraveled. Both aPKCs have pleiotropic context-dependent functions that can translate into ...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/j.ccell.2019.07.010
更新日期：2019-09-16 00:00:00
abstract：:Myeloid-derived suppressor cells (MDSCs) play a major role in cancer. MDSC expansion is closely associated with tumor progression, but molecular mechanisms of this expansion remain poorly understood. In this issue of Cancer Cell, Strauss and colleagues describe the roles of the nuclear receptor ROR1C in the regulation...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2015.07.007
更新日期：2015-08-10 00:00:00
abstract：:Glioma-initiating cells (GICs) are responsible for the initiation and recurrence of gliomas. Here, we identify a molecular mechanism that regulates the self-renewal capacity of patient-derived GICs. We show that TGF-beta and LIF induce the self-renewal capacity and prevent the differentiation of GICs. TGF-beta induces...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2009.02.011
更新日期：2009-04-07 00:00:00
abstract：:MDM2, a negative regulator of p53, is elevated in many cancers that retain wild-type p53. A single nucleotide polymorphism (SNP) in the human MDM2 promoter increases the affinity of Sp1 resulting in elevated MDM2 levels. We generated mice carrying either the MDM2(SNP309T) or the MDM2(SNP309G) allele to address the imp...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2010.07.010
更新日期：2010-09-14 00:00:00
abstract：:HIF-2alpha promotes von Hippel-Lindau (VHL)-deficient renal clear cell carcinoma (RCC) tumorigenesis, while HIF-1alpha inhibits RCC growth. As HIF-1alpha antagonizes c-Myc function, we hypothesized that HIF-2alpha might enhance c-Myc activity. We demonstrate here that HIF-2alpha promotes cell-cycle progression in hypo...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2007.02.006
更新日期：2007-04-01 00:00:00
abstract：:Recent genome sequencing efforts have identified millions of somatic mutations in cancer. However, the functional impact of most variants is poorly understood. Here we characterize 194 somatic mutations identified in primary lung adenocarcinomas. We present an expression-based variant-impact phenotyping (eVIP) method ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2016.06.022
更新日期：2016-08-08 00:00:00
abstract：:Elucidating the determinants of aggressiveness in lethal prostate cancer may stimulate therapeutic strategies that improve clinical outcomes. We used experimental models and clinical databases to identify GATA2 as a regulator of chemotherapy resistance and tumorigenicity in this context. Mechanistically, direct upregu...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2014.11.013
更新日期：2015-02-09 00:00:00
abstract：:We used small molecule screening to discover compounds and mechanisms for overcoming E6 oncogene-mediated drug resistance. Using high-throughput screening in isogenic cell lines, we identified compounds that potentiate doxorubicin's lethality in E6-expressing colon cancer cells. Such compounds included quaternary ammo...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2006.01.012
更新日期：2006-02-01 00:00:00
abstract：:Here, we show that tumor ADORA1 deletion suppresses cell growth in human melanoma cell lines in vitro and tumor development in vivo in immune-deficient xenografts. However, this deletion induces the upregulation of PD-L1 levels, which inactivates cocultured T cells in vitro, compromises anti-tumor immunity in vivo, an...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2020.02.006
更新日期：2020-03-16 00:00:00
abstract：:Somatic loss-of-function mutations in the ten-eleven translocation 2 (TET2) gene occur in a significant proportion of patients with myeloid malignancies. Although there are extensive genetic data implicating TET2 mutations in myeloid transformation, the consequences of Tet2 loss in hematopoietic development have not b...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2011.06.001
更新日期：2011-07-12 00:00:00
abstract：:The telomere-stabilizing enzyme telomerase is induced in tumors and functionally associated with unlimited replicative potential. To further explore its necessity, transgenic mice expressing SV40 or HPV16 oncogenes, which elicit carcinomas in pancreas and skin, respectively, were rendered telomerase-deficient. Absence...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2004.08.032
更新日期：2004-10-01 00:00:00
